AIM
ELV icon

Advantage Investment Management’s Elevance Health ELV Stock Holding History

Advantage Investment Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$98K Sell
407
-51
-11% -$14K 0.08% 237
2019
Q2 		$129K Buy
458
+42
+10% +$11.5K 0.1% 199
2019
Q1 		$119K Buy
416
+10
+2% +$2.89K 0.09% 213
2018
Q4 		$107K Buy
406
+10
+3% +$2.75K 0.08% 223
2018
Q3 		$109K Buy
396
+81
+26% +$21K 0.07% 261
2018
Q2 		$75K Buy
315
+55
+21% +$12.7K 0.05% 303
2018
Q1 		$57K Hold
260
– – 0.02% 361
2017
Q4 		$59K Sell
260
-9
-3% -$1.92K 0.02% 371
2017
Q3 		$51K Buy
269
+125
+87% +$23.8K 0.02% 386
2017
Q2 		$27K Buy
144
+10
+7% +$1.8K 0.01% 503
2017
Q1 		$22K Sell
134
-24
-15% -$3.82K 0.01% 525
2016
Q4 		$23K Sell
158
-68
-30% -$9.11K 0.01% 476
2016
Q3 		$28K Sell
226
-298
-57% -$38.5K 0.01% 444
2016
Q2 		$69K Hold
524
– – 0.03% 293
2016
Q1 		$73K Hold
524
– – 0.03% 266
2015
Q4 		$73K Sell
524
-312
-37% -$43K 0.04% 274
2015
Q3 		$117K Sell
836
-8
-0.9% -$1.2K 0.07% 189
2015
Q2 		$139K Buy
844
+178
+27% +$28.4K 0.07% 185
2015
Q1 		$103K Buy
666
+566
+566% +$80.6K 0.06% 236
2014
Q4 		$13K Buy
+100
New +$12.4K 0.01% 483

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

Advantage Investment Management's ELV Position: Q3 2019 in Review

Advantage Investment Management reduced its Elevance Health (ELV) stake by 11% in Q3 2019, selling an estimated $14K and leaving 407 shares worth $98K. The position accounts for 0.08% of the portfolio, ranked #237.

Advantage Investment Management first reported a position in ELV in Q4 2014 and has held it in 20 quarters since. The position peaked at $139K in Q2 2015. 1,014 funds tracked by Wall St. Rank hold ELV as of Q3 2019.

  • Advantage Investment Management held 407 shares of Elevance Health worth $98K as of Q3 2019.
  • Advantage Investment Management sold 51 Elevance Health shares in Q3 2019, an estimated $14K.
  • Elevance Health made up 0.08% of Advantage Investment Management's portfolio in Q3 2019, its #237 holding.
  • Advantage Investment Management first reported a position in Elevance Health in Q4 2014 and has held it in 20 quarters since.
  • Advantage Investment Management's Elevance Health position peaked at $139K in Q2 2015.
  • 1,014 funds tracked by Wall St. Rank held Elevance Health as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.